BLLN

BillionToOne, Inc. · NASDAQ · Healthcare · USD · 10-K for 2025, filed 2026-03-11

Figures on this page computed 2026-11-08 12:56 UTC

Last close

113.94USD

Market data, 2026-11-06

BLLN: weekly closes from 100.03 on 2025-11-07 to 113.94 on 2026-11-06, a move of +13.9%. Prices in USD.

Weekly closes, 2025-11-07 to 2026-11-06

Over that span: +13.9%

Except where said otherwise: 10-K for 2025, filed 2026-03-11

633.0xP/E
Price / Earnings per Share (diluted)
Source
computed
Fiscal year
2025
Accession
0002070849-26-000017
Reported in
USD
- computed
- 10-K for 2025, filed 2026-03-11
The filing itself
16.6%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Fiscal year
2025
Accession
0002070849-26-000017
Reported in
USD
- 10-K for 2025, filed 2026-03-11
- 10-K for 2025, filed 2026-03-11
- 10-K for 2025, filed 2026-03-11
- 10-Q for 2025, filed 2026-11-04
- 10-K for 2025, filed 2026-03-11
- 10-Q for 2025, filed 2026-11-04
The filing itself
2.4%Net margin
Net Income / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0002070849-26-000017
Reported in
USD
- 10-K for 2025, filed 2026-03-11
- 10-K for 2025, filed 2026-03-11
The filing itself
5.2%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0002070849-26-000017
Reported in
USD
- 10-K for 2025, filed 2026-03-11
- 10-K for 2025, filed 2026-03-11
The filing itself
0.23Debt/equity
Total Debt / Shareholders' Equity
Source
computed
Fiscal year
2025
Accession
0002070849-26-000017
Reported in
USD
- 10-K for 2025, filed 2026-03-11
- 10-Q for 2025, filed 2026-11-04
The filing itself
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed

Price is the furthest below its sector's middle: 0.04 against 0.36 on the market's range.

What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.

Five bars, one line

lens 7 of 9

1.73x

-0.19x

-0.52x

1.00x

1.17x

SalesProfitFree cash flowDebtPrice

Each bar against this company's own average; the line is that average.

Filed2025

Market data2026-11-06

Each against its own average

5 of 5 read

Except where said otherwise: 10-K for 2025, filed 2026-03-11

Sales1.73x
Its own average over 3 years, 176.5M.
Profit-0.19x
Its own average over 3 years, -38.9M.
Free cash flow-0.52x
Its own average over 3 years, -30.3M.
Debt1.00x
Its own average over 2 years, 109.1M.
Price1.17x
Its own average over 2 years, 97. Market data, 2026-11-06

Free cash flow is furthest from its own average, at -0.52 times.

The filed years, as a table

Each line is 100 at 2023-12-31, the first year we hold.

Filed year	Sales	Shares in issue
2023-12-31	100.0	100.0
2024-12-31	212.7	103.0
2025-12-31	425.4	217.0

How sales was got

Source: filed
Statement: income
Fiscal year: 2025
Accession: 0002070849-26-000017
Reported in: USD

The filing itself

How shares in issue was got

Source: filed
Statement: income
Fiscal year: 2025
Accession: 0002070849-26-000017
Reported in: USD

The filing itself

Figures behind the shape

Growth

117.9%

faster is higher, placed against 4,950 companies as of 2026-11-07

Five-year revenue growth raten/a
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed
Five-year EPS growth raten/a
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed
One-year change in net income117.9%
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed

Returns on capital

16.6%

higher is higher, placed against 5,089 companies as of 2026-11-07

Return on invested capital16.6%
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Fiscal year
2025
Accession
0002070849-26-000017
Reported in
USD
- 10-K for 2025, filed 2026-03-11
- 10-K for 2025, filed 2026-03-11
- 10-K for 2025, filed 2026-03-11
- 10-Q for 2025, filed 2026-11-04
- 10-K for 2025, filed 2026-03-11
- 10-Q for 2025, filed 2026-11-04
The filing itself
Return on equity1.6%
Net Income / Shareholders' Equity x 100
Source
computed
Fiscal year
2025
Accession
0002070849-26-000017
Reported in
USD
- 10-K for 2025, filed 2026-03-11
- 10-Q for 2025, filed 2026-11-04
The filing itself
Return on assets1.2%
Net Income / Total Assets x 100
Source
computed
Fiscal year
2025
Accession
0002070849-26-000017
Reported in
USD
- 10-K for 2025, filed 2026-03-11
- 10-Q for 2025, filed 2026-11-04
The filing itself

Margins

68.3%

wider is higher, placed against 3,412 companies as of 2026-11-07

Gross margin68.3%
Gross Profit / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0002070849-26-000017
Reported in
USD
- 10-K for 2025, filed 2026-03-11
- 10-K for 2025, filed 2026-03-11
The filing itself
Operating margin5.3%
Operating Income / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0002070849-26-000017
Reported in
USD
- 10-K for 2025, filed 2026-03-11
- 10-K for 2025, filed 2026-03-11
The filing itself
Net margin2.4%
Net Income / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0002070849-26-000017
Reported in
USD
- 10-K for 2025, filed 2026-03-11
- 10-K for 2025, filed 2026-03-11
The filing itself
Free cash flow margin5.2%
Free Cash Flow / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0002070849-26-000017
Reported in
USD
- 10-K for 2025, filed 2026-03-11
- 10-K for 2025, filed 2026-03-11
The filing itself

Price

633.0x

cheaper is higher, placed against 4,362 companies as of 2026-11-07

Price to earnings633.0x
Price / Earnings per Share (diluted)
Source
computed
Fiscal year
2025
Accession
0002070849-26-000017
Reported in
USD
- computed
- 10-K for 2025, filed 2026-03-11
The filing itself
Price to book11.2x10-Q for 2025, filed 2026-11-04
Price / Book Value per Share, where BVPS = Shareholders' Equity / Diluted Shares
Source
computed
Fiscal year
2025
Accession
0002070849-26-000082
Reported in
USD
- computed
- 10-Q for 2025, filed 2026-11-04
- computed
- 10-K for 2025, filed 2026-03-11
The filing itself
EV to EBITDA217.7x
Enterprise Value / EBITDA, where EV = Market Cap + Total Debt - Cash
Source
computed
Fiscal year
2025
Accession
0002070849-26-000017
Reported in
USD
- computed
- 10-K for 2025, filed 2026-03-11
- 10-K for 2025, filed 2026-03-11
- 10-Q for 2025, filed 2026-11-04
- 10-K for 2025, filed 2026-03-11
The filing itself
Price to sales ratio17.6x
Market Cap / Revenue, where Market Cap = Price x Diluted Shares
Source
computed
Fiscal year
2025
Accession
0002070849-26-000017
Reported in
USD
- computed
- 10-K for 2025, filed 2026-03-11
- 10-K for 2025, filed 2026-03-11
The filing itself

Safety

0.23

safer is higher, placed against 3,227 companies as of 2026-11-07

Debt to equity0.23
Total Debt / Shareholders' Equity
Source
computed
Fiscal year
2025
Accession
0002070849-26-000017
Reported in
USD
- 10-K for 2025, filed 2026-03-11
- 10-Q for 2025, filed 2026-11-04
The filing itself
Current ratio11.6910-Q for 2025, filed 2026-11-04
Current Assets / Current Liabilities
Source
computed
Fiscal year
2025
Accession
0002070849-26-000082
Reported in
USD
- 10-Q for 2025, filed 2026-11-04
- 10-Q for 2025, filed 2026-11-04
The filing itself
Interest coverage168.7x
Operating Income / Interest Expense
Source
computed
Fiscal year
2025
Accession
0002070849-26-000017
Reported in
USD
- 10-K for 2025, filed 2026-03-11
- 10-K for 2025, filed 2026-03-11
The filing itself
Altman Z-Score22.08
1.2 x A + 1.4 x B + 3.3 x C + 0.6 x D + 1.0 x E (A=WC/TA, B=RE/TA, C=EBIT/TA, D=MktCap/TL, E=Rev/TA)
Source
computed
Taken on
2026-11-07
Reported in
USD
- Computed from the 10-K for 2025, filed 2026-03-11
- Computed from the 10-K for 2025, filed 2026-03-11
- Computed from the 10-K for 2025, filed 2026-03-11
- Computed from the 10-K for 2025, filed 2026-03-11
- Computed from the 10-K for 2025, filed 2026-03-11

What it pays out

n/a

We do not hold this figure for this company, so there is nothing to place.

more, and better covered, is higher, with no cohort held

Dividend yieldn/a
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed
Payout ration/a
We do not hold this figure for this company, so there is nothing to place.
Common Dividends Paid / Net Income x 100, both from the latest filed fiscal year
Source
computed
Fiscal year
2025
Accession
0002070849-26-000017
Reported in
USD
- 10-K for 2025, filed 2026-03-11
- Computed from the 10-K for 2025, filed 2026-03-11
- 10-K for 2025, filed 2026-03-11
The filing itself
Dividend cover ration/a
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed

Share a finding

A link to the finding, not to you: it carries nothing about your account.